RWE GENESYSTerms & Conditions

Terms & Conditions

Welcome to our website. If you continue to browse and use this website, you are agreeing to comply with and be bound by these terms and conditions of use, which together with our privacy policy govern RWE Genesys’s relationship with you in relation to this website. If you disagree with any part of these terms and conditions, please do not use our website.

The term RWE Genesys, the business name of Evidence For Access Ltd., or ‘us’ or ‘we’ refer to the owner of the website whose head office is Suite 36, 88-90 Hatton Garden, Holborn, London, EC1N 8PG. Our company registration number is 09496042 and our registered address is: B1 Business Centre Suite 206, Davyfield Road, Blackburn, Lancashire, England, BB1 2QY. The term ‘you’ refers to the user or viewer of our website.

The use of this website is subject to the following terms of use:

Latest News

RWE Genesys sponsor conference session at 4th Annual Pharmacon Asia 2017,  19-22 September, One Farrer Hotel & Spa, Singapore

RWE Genesys sponsor conference session at 4th Annual Pharmacon Asia 2017, 19-22 September, One Farrer Hotel & Spa, Singapore

Read
Nanoparticles are changing the face of biomedical research

Nanoparticles are changing the face of biomedical research

Read
Economist Report: A chance finding may lead to a treatment for multiple sclerosis

Economist Report: A chance finding may lead to a treatment for multiple sclerosis

Read
Colette Hamilton is an approved speaker on leveraging real world evidence at the Pharma Market Access and Pricing Summit Asia in Singapore 20/21 September 2017

Colette Hamilton is an approved speaker on leveraging real world evidence at the Pharma Market Access and Pricing Summit Asia in Singapore 20/21 September 2017

Read